These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14449475)

  • 1. [Antibody response after administration of influenza monovaccine and bivaccine (type A2 and B)].
    HRBKA A; MALEK J
    Cesk Epidemiol Mikrobiol Imunol; 1962 Mar; 11():79-82. PubMed ID: 14449475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody reaction and effectivity of the inactivated Czechoslovak influenza monovaccine A2 Hong Kong68 (H3N2) in influenza epidemic in 1971 (author's transl)].
    Bruj J; Skocil V; Lipovský A
    Cesk Epidemiol Mikrobiol Imunol; 1974 Jan; 23(1):33-40. PubMed ID: 4280938
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIBODY responses and clinical reactions with saline and oil adjuvant influenza virus vaccines.
    The Medical Research Council's Committee
    Br Med J; 1955 Nov; 2(4950):1229-32. PubMed ID: 13269837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dosage and interval between injections on the antibody response to polyvalent influenza vaccine.
    MOGABGAB WJ; HOLMES B; BRIGHTWELL RJ; RESLER CW
    J Lab Clin Med; 1961 Sep; 58():391-404. PubMed ID: 13771680
    [No Abstract]   [Full Text] [Related]  

  • 6. THE OCCURENCE OF RHEUMATOID FACTOR IN ASSOCIATION WITH ANTIBODY RESPONSE TO INFLUENZA A2(ASIAN) VIRUS.
    SVEC KH; DINGLE JH
    Arthritis Rheum; 1965 Aug; 8():524-9. PubMed ID: 14323541
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody response to influenza vaccines combined with hexadecylamine.
    WOODHOUR AF; JENSEN KE; WARREN J
    Proc Soc Exp Biol Med; 1960 Jan; 103():200-4. PubMed ID: 13845858
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination of an adolescent group with A (H3N2) + A(HSW1N1) bivaccine before an A (H1N1) influenza epidemic.
    Stumpa A; Cihla F; Tůmová B; Husek V; Slezácek J
    Acta Virol; 1979 Sep; 23(5):443-5. PubMed ID: 42307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to polyvalent influenza virus vaccine administered intradermally or subcutaneously in an aged population.
    SASLAW S; CARLISLE HN; SLUTZKER B
    Am J Med Sci; 1963 Apr; 245():387-98. PubMed ID: 13986653
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody response to A/Asian component of polyvalent influenza virus vaccine.
    DUXBURY AE; WARBURTON MF; GREVILLE RW
    Med J Aust; 1959 Jun; 1(24):790-3. PubMed ID: 13666176
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute respiratory infections in civilian adults. I. Antibody response to polyvalent influenza--adenovirus inactivated vaccine.
    COX F; TIMM EA; QUINN EL; COLVILLE JM; McLEAN IW
    Henry Ford Hosp Med Bull; 1962 Mar; 10():27-33. PubMed ID: 13881896
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response in man to two doses of polyvalent influenza virus vaccine.
    WARBURTON MF; DUXBURY AE; GREVILLE RW
    Med J Aust; 1959 Jun; 1(24):786-90. PubMed ID: 13666175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 15. NEW RESEARCH ON INFLUENZA: STUDIES WITH NORMAL VOLUNTEERS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.
    KNIGHT V; KASEL JA; ALFORD RH; LODA F; MORRIS JA; DAVENPORT FM; ROBINSON RQ; BUESCHER EL
    Ann Intern Med; 1965 Jun; 62():1307-25. PubMed ID: 14295514
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza immunization: clinical studies with ether-split subunit vaccines.
    Brandon FB; Cox F; Quinn E; Timm EA; McLean IW
    Bull World Health Organ; 1969; 41(3):629-37. PubMed ID: 5309487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to influenza vaccines containing the Asian strain.
    CULVER JO; LENNETTE EH; STEVENS TE; NITZ RE
    J Immunol; 1960 Aug; 85():197-202. PubMed ID: 13813267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study, by means of the conditioned reflex method, of the immunogenic power of formolized rabies and influenza vaccines].
    NICOLAU SS; MIRZA L; SAMUEL I
    Stud Cercet Inframicrobiol; 1961; 12(Suppl)():175-93. PubMed ID: 14479542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunogenic properties of living anti-influenza vaccine and causes of infection of vaccinated subjects].
    ZAKSTEL'SKAIA LIa; IAKHNO MA; EFINOVA VA
    Vopr Virusol; 1957; 2(4):213-9. PubMed ID: 13530878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.